Dimitrios Iliopoulos is a worldwide renowned expert in the field of drug discovery and quantitative analysis. He has developed an innovative strategy that has revolutionized and expedited the drug discovery process. This strategy has resulted in the discovery of novel drugs for cancer and auto-immune diseases during the last 8 years. His pioneering work revealed that metformin, an anti-diabetic drug, had anti-cancer properties and led to the initiation of multiple phase clinical trials.
